Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 14 Prostatic Neoplasms 9 Leukemia, Myeloid, Acute 9 Endometrial Neoplasms 8 Breast Neoplasms 7 Oropharyngeal Neoplasms 5 Neoplasm Metastasis 5 Melanoma 5 Lung Neoplasms 5 Colonic Neoplasms 5 Squamous Cell Carcinoma of Head and Neck 4 Neoplasms 4 Multiple Myeloma 4 Lymphoma, Mantle-Cell 4 Lymphoma, Large B-Cell, Diffuse 4 Leukemia, Myelomonocytic, Acute 4 Leukemia, Monocytic, Acute 4 Leukemia, Megakaryoblastic, Acute 4 Leukemia, Lymphocytic, Chronic, B-Cell 4 Leukemia, Erythroblastic, Acute 4 Congenital Abnormalities 4 Colorectal Neoplasms 4 Stomach Neoplasms 3 Rectal Neoplasms 3 Neuroblastoma 3 Mouth Neoplasms 3 Lymphoma, Follicular 3 Leukemia 3 Esophageal Neoplasms 3 Brain Neoplasms 3

Interventions

Standard of Care 8 Hydroxychloroquine 4 BNT162 Vaccine 4 Practice Guidelines as Topic 3 Blood Specimen Collection 3 2019-nCoV Vaccine mRNA-1273 3 tocilizumab 2 sotrovimab 2 cilgavimab and tixagevimab drug combination 2 Specimen Handling 2 Sodium Chloride 2 CVnCoV COVID-19 vaccine 2 COVID-19 Vaccines 2 COH04S1 COVID-19 vaccine 2 Azithromycin 2 sinovac COVID-19 vaccine 1 selinexor 1 remdesivir 1 proxalutamide 1 palbociclib 1 ogalvibart 1 monalizumab 1 lenzilumab 1 crexavibart 1 ciclesonide 1 bemcentinib 1 avdoralimab 1 acalabrutinib 1 XAV-19 1 Therapeutics 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × COVID-19 × Observation × Clear all

NCT04442048 2025-12-30

COV-IMMUNO

Canadian Cancer Trials Group

Phase 3 Completed

COVID-19, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡